SCHEMBL6946469

SCHEMBL6946469

Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCCCN3C(=O)OC(C)(C)C)n2)cc1C

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.63
BRD4 O60885 3/20 0.63
BRDT Q58F21 3/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7168832 0.93 MAPK14 (0.63) MAPK14BRD4BRDT
SCHEMBL6943768 0.91 MAPK14 (0.62) MAPK14BRD4BRDT
SCHEMBL6951373 0.91 MAPK14 (0.66) MAPK14BRD4BRDT
SCHEMBL6955184 0.91 MAPK14 (0.62) MAPK14BRD4BRDT
SCHEMBL7078025 0.90 MAPK14 (0.63) MAPK14BRD4BRDT
SCHEMBL6952383 0.90 MAPK14 (0.64) MAPK14BRD4BRDT
SCHEMBL6949073 0.89 MAPK14 (0.64) MAPK14BRD4BRDT
SCHEMBL6955625 0.89 MAPK14 (0.63) MAPK14BRD4BRDT
SCHEMBL6947745 0.88 MAPK14 (0.68) MAPK14BRD4BRDT
SCHEMBL6955585 0.87 MAPK14 (0.63) MAPK14BRD4BRDT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996446-B1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2003-09-17 EP disclosed
US-6562832-B1 Cytokine suppressive anti-inflammatory drugs, capable of inhibiting the CSBP/p38/RK kinase SMITHKLINE BEECHAM CORPORATION 2003-05-13 US disclosed
EP-0996446-A4 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2001-08-29 EP disclosed
EP-0996446-A1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2000-05-03 EP disclosed
US-6046208-A TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, ENDOTOXEMIA AND/OR TOXIC SHOCK SYNDROME, OTHER ACUTE OR CHRONIC INFLAMMATORY DISEASE STATES SUCH AS THE INFLAMMATORY REACTION INDUCED BY ENDOTOXIN OR INFLAMMATORY BOWEL DISEASE SMITHKLINE BEECHAM CORPORATION (US) 2000-04-04 US disclosed
WO-1999001131-A1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1999-01-14 WO disclosed